Casado et al. have shown overexpression of TFF3 and Bcl2 in colonic carcinoma following neoadjuvant therapy suggesting that TFF3 might induce Bcl2, block apoptosis and prevent colonic cancer cell death following neoadjuvant therapy [24]. The gene discussed is BCL2; the disease is colonic neoplasm.